SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-24-020377
Filing Date
2024-04-17
Accepted
2024-04-17 17:26:22
Documents
20
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20023925x2_pre14a.htm   iXBRL PRE 14A 1315589
6 GRAPHIC logo_rocketpharma.jpg GRAPHIC 29648
7 ny20023925x2_pc01.jpg GRAPHIC 593429
8 ny20023925x2_pc02.jpg GRAPHIC 609036
9 ny20023925x2_pvpchart01x1.jpg GRAPHIC 121465
10 ny20023925x2_pvpchart03x1.jpg GRAPHIC 117413
  Complete submission text file 0001140361-24-020377.txt   6045906

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA rckt-20240613.xsd EX-101.SCH 5911
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE rckt-20240613_def.xml EX-101.DEF 6091
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE rckt-20240613_lab.xml EX-101.LAB 19690
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE rckt-20240613_pre.xml EX-101.PRE 9758
23 EXTRACTED XBRL INSTANCE DOCUMENT ny20023925x2_pre14a_htm.xml XML 254092
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36829 | Film No.: 24852080
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)